China has emerged as a global leader in medical AI development, with over 100 NMPA-approved AI medical software products. Several Chinese AI companies have achieved certifications that enable global deployment — FDA clearance, CE marking, and even WHO Prequalification.
Key Players
Infervision — The first Chinese AI company to receive WHO Prequalification for chest CT AI. Deployed in 20+ countries and 1,000+ healthcare institutions.
United Imaging uAI — 140+ AI applications covering cardiovascular, neurological, respiratory, and oncology imaging. Deeply integrated with United Imaging's hardware ecosystem.
Lepu Medical AI-ECG — The only AI-ECG product simultaneously certified by NMPA, FDA, and CE. Achieves 1-second ECG diagnosis.
Why Hospitals Are Adopting
AI triage reduces radiologist reading time by 30-50%. In resource-limited settings, AI can compensate for the shortage of specialist physicians. The ROI is clear: faster diagnosis, higher throughput, and improved accuracy.
Deployment Models
Chinese AI companies offer flexible deployment: on-premise, cloud (AWS/Azure/GCP), hybrid, and edge (pre-installed on devices). SaaS pricing starts at $5,000/year for small clinics.